-
1
-
-
80054872790
-
Alcoholic liver disease: pathogenesis and new therapeutic targets
-
Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011; 141: 1572-1585.
-
(2011)
Gastroenterology
, vol.141
, pp. 1572-1585
-
-
Gao, B.1
Bataller, R.2
-
2
-
-
41549112441
-
Treatment of alcoholic liver disease
-
Barve A, Khan R, Marsano L, Ravindra KV, McClain C. Treatment of alcoholic liver disease. Ann Hepatol 2008; 7: 5-15.
-
(2008)
Ann Hepatol
, vol.7
, pp. 5-15
-
-
Barve, A.1
Khan, R.2
Marsano, L.3
Ravindra, K.V.4
McClain, C.5
-
4
-
-
0030716183
-
Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat
-
Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. HEPATOLOGY 1997; 26: 1530-1537.
-
(1997)
HEPATOLOGY
, vol.26
, pp. 1530-1537
-
-
Iimuro, Y.1
Gallucci, R.M.2
Luster, M.I.3
Kono, H.4
Thurman, R.G.5
-
5
-
-
0032835529
-
Essential role of tumor necrosis factor a in alcohol-induced liver injury in mice
-
Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, et al. Essential role of tumor necrosis factor a in alcohol-induced liver injury in mice. Gastroenterology 1999; 117: 942-952.
-
(1999)
Gastroenterology
, vol.117
, pp. 942-952
-
-
Yin, M.1
Wheeler, M.D.2
Kono, H.3
Bradford, B.U.4
Gallucci, R.M.5
Luster, M.I.6
-
6
-
-
57249086241
-
A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis
-
Boetticher NC, Peine CJ, Kwo P, Abrams GA, Patel T, Aqel B, et al. A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology 2008; 135: 1953-1960.
-
(2008)
Gastroenterology
, vol.135
, pp. 1953-1960
-
-
Boetticher, N.C.1
Peine, C.J.2
Kwo, P.3
Abrams, G.A.4
Patel, T.5
Aqel, B.6
-
8
-
-
84865504141
-
Sterile inflammation in the liver
-
Kubes P, Mehal WZ. Sterile inflammation in the liver. Gastroenterology 2012; 143: 1158-1172.
-
(2012)
Gastroenterology
, vol.143
, pp. 1158-1172
-
-
Kubes, P.1
Mehal, W.Z.2
-
9
-
-
84865132718
-
Inflammasomes in liver diseases
-
Szabo G, Csak T. Inflammasomes in liver diseases. J Hepatol 2012; 57: 642-654.
-
(2012)
J Hepatol
, vol.57
, pp. 642-654
-
-
Szabo, G.1
Csak, T.2
-
10
-
-
84867176929
-
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
-
Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 2012; 122: 3476-3489.
-
(2012)
J Clin Invest
, vol.122
, pp. 3476-3489
-
-
Petrasek, J.1
Bala, S.2
Csak, T.3
Lippai, D.4
Kodys, K.5
Menashy, V.6
-
11
-
-
77953891627
-
Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice
-
e7.
-
Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology 2010; 139: 323-334 e7.
-
(2010)
Gastroenterology
, vol.139
, pp. 323-334
-
-
Miura, K.1
Kodama, Y.2
Inokuchi, S.3
Schnabl, B.4
Aoyama, T.5
Ohnishi, H.6
-
12
-
-
84864545087
-
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
-
Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 2012; 11: 633-652.
-
(2012)
Nat Rev Drug Discov
, vol.11
, pp. 633-652
-
-
Dinarello, C.A.1
Simon, A.2
van der Meer, J.W.3
|